Literature DB >> 16406015

Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia.

Carlos Alberto Scrideli1, Rosane de Paula Queiróz, José Eduardo Bernardes, Ricardo Defavery, Elvis Terci Valera, Luiz Gonzaga Tone.   

Abstract

Early treatment response assessment has become an import prerequisite in the selection therapy in childhood ALL. In this study we compare classical diagnostic factors and the significance of three simplified strategies, WBC count at day 7 and a simplified PCR methodology to minimal residual disease detection on days 14 and 28, to evaluate early treatment response in 84 consecutive children with ALL. The use of these simplified methods for the evaluation of early response, proved to be a good predictor of an unfavorable course in children with ALL and could be used as a stratification criterion in treatment protocols, specially in low-budget countries.

Entities:  

Mesh:

Year:  2006        PMID: 16406015     DOI: 10.1016/j.leukres.2005.11.021

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia.

Authors:  JinFang Zhang; LingJi Zeng; YuLian Wang; JianWei Pan; XingDong Li; Bei Feng; Quan Yang
Journal:  Front Pediatr       Date:  2022-06-06       Impact factor: 3.569

2.  A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups.

Authors:  Carlos A Scrideli; Juliana G Assumpção; Mônica A Ganazza; Marcela Araújo; Silvia R Toledo; Maria Lúcia M Lee; Elisabete Delbuono; Antonio S Petrilli; Rosane P Queiróz; Andrea Biondi; Marcos B Viana; José A Yunes; Silvia R Brandalise; Luiz G Tone
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

3.  Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia.

Authors:  Kyung Nam Koh; Meerim Park; Bo Eun Kim; Ho Joon Im; Chan-Jeoung Park; Seongsoo Jang; Hyun Sook Chi; Jong Jin Seo
Journal:  Korean J Pediatr       Date:  2010-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.